Frank Graybeal

Background

About Frank Graybeal

During his 30-year career, Frank has amassed an impressive resume providing acquisition, disposition and advisory services to a wide variety of companies throughout the Washington DC Metropolitan and Baltimore markets. Frank is a Senior Vice President with CBRE. By emphasizing a proactive approach and attention to detail, coupled with a thorough knowledge of the market, Frank develops innovative strategies and opportunities for his clients. Frank leads CBRE’s Regional Life Sciences Practice Group representing clients in DC/Baltimore area including: American Type Culture Collection, Life Technologies, Aeras Global TB Vaccine, Amplimmune, MacroGenics, Eisai Pharmaceuticals and Shire Pharmaceuticals. Additionally, the firm’s National Life Sciences Practice Group (made up of 50 professionals from across the country) has executed significant assignments including the disposition of Eli Lilly’s square foot Manassas, Virginia facility and Pfizer’s square foot Skokie, Illinois campus. Partial Client List: Comsat Laboratories Sale/Lease-Back, 225-acre, sf. R&D campus, Clarksburg, MD Matra Aerospace Disposition, 55-acre, sf. corporate campus, Germantown, MD Guilford Pharmaceuticals Sale/Lease-Back, sf. Manufacturing/R&D facility, Baltimore, MD Alpharma, U.S.P.D. Advisory, sf, national locations Celera Acquisition and disposition, sf. HQ facility, Rockville, MD BioAnalytical Systems, Inc. sf. sale/lease Clinical Research Lab, Baltimore, MD Montgomery County Public Schools sf. acquisition, multiple locations Hughes Network Systems sf. acquisition, I-270 Corridor Qiagen BioSciences sf, acquisition/advisory, nationally Wellstat sf, acquisition, headquarters facility, Gaithersburg, MD Lonza Corporation sf, disposition, Baltimore, MD Emergent BioSolutions sf, acquisition, Baltimore, MD